· 10/05/2018Reclutando
Ensayo clínico OPH2005: Eficacia y seguridad de Zimura en el tratamiento de la enfermedad de Stargardt
· 03/08/2017Reclutando
The Microbiome Project: microbiota associated to Macula Diseases – µMD
· 28/07/2017
Geographic atrophy phenotype identification by cluster analysis
· 24/04/2017
Drusen Ooze: A Novel Hypothesis in Geographic Atrophy
· 30/08/2016
A Swine Model of Selective Geographic Atrophy of Outer Retinal Layers Mimicking Atrophic AMD: A Phase I Escalating Dose of Subretinal Sodium Iodate
· 06/04/2016
Feeder vessel laser photocoagulation for idiopathic, subfoveal polypoidal choroidal vasculopaty not responding to eithelial growth factor therapy or photodynamic therapy
· 06/04/2016
Direct Visualization of a New Choroidal Vessel on Spectral-Domain Optical Coherence Tomography
· 31/03/2016
Proxima A: Estudio epidemiológico para pacientes con Atrofia Geográfica secundaria a DMAE (GX29633)
· 31/03/2016
Proxima B: Estudio epidemiológico para pacientes con Atrofia Geográfica secundaria a DMAE (GX29639)
· 30/03/2016
Individualized Stabilization Criteria-Driven Ranibizumab versus Laser in Branch Retinal Vein Occlusion: Six-Month Results of BRIGHTER.
· 30/03/2016
Correspondence. Wedge-Shaped Subretinal hyporeflectivity in GA.
· 17/02/2016
Individualized Ranibizumab Regimen Driven by Stabilization Criteria for Central Retinal Vein Occlusion: Twelve-Month Results of the CRYSTAL Study.
· 21/10/2015
Scheduled versus Pro Re Nata Dosing in the VIEW Trials.
· 28/09/2015
Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
· 21/09/2015
HARRIER: Ensayo clínico en pacientes con neovascularización coroidea secundaria a DMAE